EPIX: ESSA Pharma Inc. Stock

by  •  • Comments Off on EPIX: ESSA Pharma Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 270.74
Enterprise Value ($M) 235.67
Book Value ($M) 140.68
Book Value / Share 3.18
Price / Book 1.92
NCAV ($M) 140.68
NCAV / Share 3.18
Price / NCAV 1.92

Profitability (mra)
Return on Invested Capital (ROIC) -0.18
Return on Assets (ROA) -0.16
Return on Equity (ROE) -0.17

Liquidity (mrq)
Quick Ratio 40.92
Current Ratio 40.92

Balance Sheet (mrq) ($M)
Current Assets 144.49
Assets 144.49
Liabilities 3.81
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -32.13
Net Income -26.58

Cash Flow Statement (mra) ($M)
Cash From Operations -19.78
Cash from Investing -3.53
Cash from Financing -0.07

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Rtw Investments, Lp 5.20
02-14 13G/A PFM Health Sciences, LP 7.40
02-13 13G/A Bb Biotech Ag 17.90 0.00
02-08 13G Morgan Stanley 9.50
01-23 13G/A Soleus Capital, LLC 9.80 11.84

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-12-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 24,549 168,049 14.61
2024-04-25 6,977 64,770 10.77
2024-04-24 3,052 5,918 51.57
2024-04-23 25,318 24,415 103.70
2024-04-22 58,902 16,965 347.20

(click for more detail)

Similar Companies
ENSC – Ensysce Biosciences, Inc. ENTX – Entera Bio Ltd.
ENVB – Enveric Biosciences, Inc. EQ – Equillium, Inc.
ERNA – Eterna Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io